Please use this identifier to cite or link to this item:
Title: Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy
Authors: Laucella, Susana A. 
Mazliah, Damián Pérez 
Bertocchi, Graciela 
Alvarez, María G 
Cooley, Gretchen 
Viotti, Rodolfo 
Albareda, María C 
Lococo, Bruno 
Postan, Miriam 
Armenti, Alejandro 
Tarleton, Rick L 
Issue Date: 1-Dec-2009
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 
Abstract: As many as 20 million people are living with Trypanosoma cruzi infection in Latin American, yet few receive any treatment. The major limitation in developing and evaluating potential new drugs for their efficacy is the lack of reliable tests to assess parasite burden and elimination.
DOI: 10.1086/648072
Appears in Collections:Publicaciones INP

Files in This Item:
File Description SizeFormat
nihms144587.pdfArtículo en inglés1.16 MBAdobe PDFThumbnail
Show full item record

Page view(s)

checked on Jul 2, 2020


checked on Jul 2, 2020

Google ScholarTM




Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.